ZWJ Investment Counsel Inc. Has $625,000 Stock Position in Intuitive Surgical, Inc. $ISRG

ZWJ Investment Counsel Inc. grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.2% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,150 shares of the medical equipment provider’s stock after acquiring an additional 57 shares during the quarter. ZWJ Investment Counsel Inc.’s holdings in Intuitive Surgical were worth $625,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in shares of Intuitive Surgical by 1.4% in the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock valued at $16,178,258,000 after buying an additional 453,335 shares during the last quarter. Invesco Ltd. increased its position in Intuitive Surgical by 1.7% during the 1st quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock worth $2,090,027,000 after buying an additional 71,794 shares during the period. Northern Trust Corp increased its position in Intuitive Surgical by 0.3% during the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock worth $1,798,465,000 after buying an additional 11,988 shares during the period. Wellington Management Group LLP increased its position in Intuitive Surgical by 15.0% during the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after buying an additional 457,080 shares during the period. Finally, Nuveen LLC bought a new position in shares of Intuitive Surgical in the first quarter worth $1,715,899,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on ISRG. Evercore ISI lifted their target price on Intuitive Surgical from $470.00 to $550.00 and gave the company an “in-line” rating in a research report on Tuesday, July 8th. The Goldman Sachs Group cut their price target on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a research note on Wednesday. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Saturday, September 27th. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $615.00 price objective on shares of Intuitive Surgical in a research note on Tuesday, August 19th. Finally, Erste Group Bank reiterated a “hold” rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Fourteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $594.19.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $452.35 on Friday. The stock has a 50-day simple moving average of $463.55 and a two-hundred day simple moving average of $500.00. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The firm has a market capitalization of $162.16 billion, a PE ratio of 63.09, a P/E/G ratio of 4.64 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The business had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same quarter in the previous year, the company posted $1.78 earnings per share. Intuitive Surgical’s revenue for the quarter was up 21.4% on a year-over-year basis. Equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 335 shares of the business’s stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $440.69, for a total transaction of $147,631.15. Following the completion of the sale, the director owned 739 shares of the company’s stock, valued at approximately $325,669.91. The trade was a 31.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares of the company’s stock, valued at $173,845.44. This represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 45,224 shares of company stock valued at $21,716,492. Company insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.